(Q37334707)

English

Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033481%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Europe PubMed Central

Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033481%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

drug interaction

0 references

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033481%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Chen-May Wong

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033481%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Yu Ko

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033481%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

0 references

publication date

25 November 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033481%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Annals of Pharmacotherapy

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033481%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

42

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033481%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1737-1748

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033481%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033481%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

The potential for drug interactions

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Potential drug interactions and duplicate prescriptions among cancer patients.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Overview of the changing paradigm in cancer treatment: oral chemotherapy

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

A systematic review on drug interactions in oncology

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Concordance of severity ratings provided in four drug interaction compendia

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Comparative assessment of four drug interaction compendia

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Warfarin and azathioprine: a drug interaction does exist.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

A case report of warfarin resistance due to azathioprine and review of the literature

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Azathioprine and allopurinol: the price of an avoidable drug interaction.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

The effect of metronidazole on busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

An adverse interaction between warfarin and capecitabine: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Capecitabine-warfarin interaction

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Qualitative defects of pseudocholinesterase activity

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

The effect of a series of anti-cancer drugs on plasma cholinesterase activity.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Antineoplastic agents. Drug interactions of clinical significance.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Cyclophosphamide, Cholinesterase and Anaesthesia*

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Drug interaction between gefitinib and warfarin

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Pharmacokinetic drug interactions of gefitinib with rifampicin, itraconazole and metoprolol

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Imatinib induces hypothyroidism in patients receiving levothyroxine.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Diminished anticoagulant effects of warfarin with concomitant mercaptopurine therapy

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Observations on the use of allopurinol in combination with azathioprine or mercaptopurine.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Pharmacokinetic interaction between high-dose methotrexate and amoxycillin

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Pharmacokinetic interaction between high-dose methotrexate and oxacillin.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Acute renal failure due to concomitant action of methotrexate and indomethacin

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Methotrexate and nonsteroidal antiinflammatory drug interactions

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Lack of pharmacokinetic interaction between rofecoxib and methotrexate in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Intermittent high dose oral methotrexate therapy in psoriasis

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Effect of aspirin and sulindac on methotrexate clearance

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Acute megaloblastic anemia induced by high-dose trimethoprim-sulfamethoxazole

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Methotrexate and trimethoprim-sulphamethoxazole--a potentially hazardous combination.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Increased methotrexate toxicity due to concurrent probenecid administration

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Prolongation and enhancement of serum methotrexate concentrations by probenecid

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Clinical-evaluation of ACTH and cortisone in myasthenia gravis.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Impact of ketoconazole on the metabolism of prednisolone

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Stimulatory effect of N-phenylbarbital (phetharbital) on cortisol hydroxylation in man.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Effects of Diphenylhydantoin, Phenobarbital, and Diazepam on the Metabolism of Methylprednisolone and Its Sodium Succinate

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Effects of enzyme induction on metabolism of prednisolone. Clinical and laboratory study

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Loss of therapeutic control in congenital adrenal hyperplasia due to interaction between dexamethasone and primidone

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

The effect of intra-articular steroids on plasma salicylate concentrations

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Interaction of salicylate and corticosteroids in man.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Sirolimus and ketoconazole co-prescription in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Drug interaction between itraconazole and sirolimus in a primary renal allograft recipient

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Sirolimus-itraconazole interaction in a hematopoietic stem cell transplant recipient.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Pharmacokinetic interaction between single oral doses of diltiazem and sirolimus in healthy volunteers

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Pharmacokinetic Interactions between Sirolimus and Microemulsion Cyclosporine When Orally Administered Jointly and 4 Hours Apart in Healthy Volunteers

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Therapeutic drug monitoring of sirolimus: effect of concomitant immunosuppressive therapy and optimization of drug dosing

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Differentiation of innovator versus generic cyclosporine via a drug interaction on sirolimus.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Oral cancer treatment: developments in chemotherapy and beyond

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Differences between clinical trials and postmarketing use.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Value of postmarketing surveillance studies in achieving a complete picture of antimigraine agents: using almotriptan as an example

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1L255

21 January 2018

Identifiers

10.1345/APH.1L255

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033481%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19033481%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37334707&oldid=1547678957"